Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Southern Medical Journal|November 3, 2020
Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic EncephalopathyPatricia P Bloom, Samuel J Miller, Rahul K Nayak, et al.
JMIR Medical Informatics|September 3, 2020
A Smartphone App to Manage Cirrhotic Ascites Among Outpatients: Feasibility StudyPatricia Bloom, Thomas Wang, Madeline Marx, et al.
The American Journal of Gastroenterology|April 30, 2024
Natural History of Indeterminate Liver Nodules in Patients With Advanced Liver Disease: A Multicenter Retrospective Cohort StudyAmit G Singal, Neehar D Parikh, Kirti Shetty, et al.
Hepatology Communications|September 24, 2021
Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver DiseaseAshwini Arvind, Jacqueline B Henson, Stephanie A Osganian, et al.
Hepatology Communications|March 27, 2023
Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolizationIhab Kassab, Amit G Singal, Aamir Ali, et al.
Liver Cancer|June 25, 2026
Modality-Specific and Multilevel Barriers to Curative Treatment for Early-Stage Hepatocellular CarcinomaAshwini Arvind, Lisa Quirk, Sneha Deodhar, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 11, 2024
Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysisAshwini Arvind, Karim Seif El Dahan, Riya Malhotra, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 31, 2019
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planningEmily Bethea, Ashwini Arvind, Jenna Gustafson, et al.
JHEP Reports : Innovation in Hepatology|February 12, 2026
Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real studyCiro Celsa, Tiziana Pressiani, Naoshi Nishida, et al.
Abdominal Radiology (New York)|September 27, 2024
Is concurrent LR-5 associated with a higher rate of hepatocellular carcinoma in LR-3 or LR-4 observations? An individual participant data meta-analysisNicole Abedrabbo, Emily Lerner, Eric Lam, et al.
Pageof 3